drugset / Trial / NCT05008042

Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia

NCT05008042

RandomizedParallel-groupDouble-blindTreatment

Summary

Fibromyalgia causes long term pain where mostly women are affected. It is not entirely clear how vitamin B12 affects the human pain system, there are however many primary studies that indicate different interesting approaches. Considering that the receptor of NMDA is involved in both long-term pain and vitamin B12 deficiency its of most importance to evaluate whether vitamin B12 decreases the pain sensitivity and the experience of pain i.e hyperalgesia and allodynia, at persons with fibromyalgia.The aim of this study is therefore to evaluate the effect of Mecobalamin (vitamin B12), and describe lived experiences of pain, health, suffering and well-being in women with diagnosed fibromyalgia.

Timeline

Start
2019-02-06
Primary completion
2024-03-26
Completion
2024-03-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator methylcobalamin Small molecule 10 mg Intramuscular

Indications